Published by Coherent Market Insights
Posted on September 27, 2021
4 min readLast updated: February 2, 2026
The bioimplants market is projected to grow at a CAGR of 5.7% from 2021 to 2028, driven by innovations and rising demand due to chronic diseases.
The global bio-implants market was valued at US$ 73,947.4 million in 2021 and is expected to exhibit a CAGR of 5.7% over the forecast period (2021-2028).
Bio-implants are bioengineered products made up of biomaterials such as collagen and tissue engineered products, which includes artificial skin and tissue. Bio-implants are used in organ transplantation and replacement of tissues, which enhance the functionality of affected body organs. Bio-implants has wide range of application in cardiovascular, orthopedic, neurological, dental, and other therapeutic areas. Bio-implants are significant in improving longevity and quality of human life.
Request a sample copy of help grow your business @
https://www.coherentmarketinsights.com/insight/request-sample/3050
Key participants for business development are Abbott, Dentsply Sirona Plc, Medtronic, Stryker Corporation, Zimmer Biomet, B.Braun, Cook Medical, C.R. Bard, Edwards Lifesciences, Wright Medical technology, and Boston Scientific Corporation.
Increasing prevalence of chronic diseases such as cardiovascular diseases (CVD) and arthritis is expected to increase the demand for bio-implants, which in turn is expected to fuel the bio-implants market growth over the forecast period. For instance, according to the World Health Organization (WHO) 2017 statistics, cardiovascular diseases accounted for around 17.9 million deaths in 2016. Moreover, according to the Centers for Disease Control and Prevention (CDC), in May 2019, around 54.4 million of U.S. adults were diagnosed with arthritis.
Manufacturers and researchers are focused on developing the advanced systems for treating medication resistant epilepsy patients using a deep brain stimulation implant similar to a cardiac pacemaker. For instance, in February 2019, Medtronic launched Deep Brain Stimulation (DBS) implant for reducing epileptic seizures. DBS provides an important surgical treatment option for patients, who suffer from epilepsy and do not respond to medication.
Moreover, key players operating in the market are focusing on strategic investment in order to develop and commercialize new products and expand its market presence. For instance, in February 2019, GT Medical Technologies raised US$ 10 million funding to help support commercialization of its GammaTile Therapy, a bioresorbable implant designed to deliver local doses of radiation to patients with brain tumors.
Reasons to Purchase this Report
Current and future of global Bioimplants market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
Regions/countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Buy This Complete A Business Report With Flat US $2000 Off @
https://www.coherentmarketinsights.com/promo/buynow/3050
Years Considered to Estimate the Bioimplants Market Size:
History Year: 2016-2020
Base Year: 2020
Forecast Year: 2021-2028
Important Features and Key Highlights of the Market:-
Download PDF Brochure of help grow your business @
https://www.coherentmarketinsights.com/insight/request-pdf/3050
Note: Access insightful study with over 150+ pages, list of tables & figures, profiling 20+ companies.
Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.
Contact us:
Mr. Shah
Senior Client Partner – Business Development
sales@coherentmarketinsights.com
www.coherentmarketinsights.com
The post Bioimplants Market Future Scope, Overall Study, Opportunities and Forecast 2021-2028 | Abbott, Dentsply Sirona, Medtronic, Stryker Corporation appeared first on Gatorledger.
The article discusses the growth and future scope of the global bioimplants market from 2021 to 2028.
What are the key factors driving the bioimplants market growth?
Which companies are leading in the bioimplants market?
Explore more articles in the Research Reports category
